AKT1 and neoplasm: So far, PSGL-1 ligation on exhausted T-cells resulted in diminished ERK (extracellular signal-regulated kinases) and AKT (Protein kinase B) signaling (24), and constrains its metabolic activity, thereby, limiting anti-tumor response (54).